A novel fluorescent recombinant cell-based biosensor for screening NLRP3 inflammasome inhibitors

被引:6
|
作者
Ye, Yongli [1 ]
Liu, Kaiqin [1 ]
Geng, Shuxiang [2 ]
Ji, Jian [1 ]
Sun, Jiadi [1 ]
Zhang, Yinzhi [1 ]
Pi, Fuwei [1 ]
Sun, Xiulan [1 ]
机构
[1] Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci, Natl Engn Res Ctr Funct Food,Synerget Innovat Ctr, Wuxi 214122, Jiangsu, Peoples R China
[2] Yunnan Acad Forestry, Kunming 650201, Yunnan, Peoples R China
关键词
NLRP3; inflammasome; Fluorescence; Cell-based biosensor; Phenols; Glabridin; OXIDATIVE STRESS-RESPONSE; LYSOSOMAL DAMAGE; ACTIVATION; RECEPTOR;
D O I
10.1016/j.snb.2019.126864
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Nucleotide-binding oligomerization domain-like receptor pyrin-domain-containing protein 3 (NLRP3) inflammasomes trigger a defense mechanism in response to physiological or pathological reactions caused by various injuries, and they have critical roles in the development of many major diseases. The development of plant source anti-inflammatory agents and the assessment of their anti-inflammatory properties still face many challenges, such as high costs and long testing periods. Exogenous anti-inflammatory factors can be evaluated at the protein level using the NLRP3-green fluorescent protein (GFP) THP-1 cell-based biosensor. To achieve this, THP-1 cells were stably transfected with a plasmid encoding the GFP reporter gene that is under the transcriptional regulation of the NLRP3 promoter. Because the NLRP3 promoter controls the green fluorescent signal, the fluorescence is an indicator of NLRP3 activity. Our results show the fluorescence intensity was dependent on both the degree of inflammation and the effect of the anti-inflammatory agent. Here, we successfully used the biosensor to screen an NLRP3 inhibitor in the presence of polyphenols. Our results demonstrate the potential of this cell-based biosensor in monitoring the development of inflammation and in screening inflammatory inhibitors.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] NLRP3 inflammasome activation and cell death
    Yi Huang
    Wen Xu
    Rongbin Zhou
    Cellular & Molecular Immunology, 2021, 18 : 2114 - 2127
  • [22] NLRP3 inflammasome activation and cell death
    Huang, Yi
    Xu, Wen
    Zhou, Rongbin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (09) : 2114 - 2127
  • [23] Cell Swelling and the NLRP3 Inflammasome Response
    Angosto, Diego
    Lopez-Castejon, Gloria
    Mulero, Victoriano
    Pelegrin, Pablo
    IMMUNITY, 2013, 38 (03) : 400 - 401
  • [24] Screening-based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
    Cui, Wenyu
    Chen, Sheng
    Chi, Zhexu
    Guo, Xingchen
    Zhang, Xiaobo
    Zhong, Yueyang
    Han, Haijie
    Yao, Ke
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (07):
  • [25] Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors
    Kang, Tongtong
    Sun, Simin
    Wang, Huimin
    Liu, Jinyu
    Li, Xiaoyang
    Jiang, Yuqi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 113
  • [26] Novel Macrocyclic NLRP3 Inhibitors
    Mesch, Stefanie
    Shannon, Jonathan
    Miller, David
    Macleod, Angus
    Bouche, Lea
    Johnston, Heather J.
    Matthews, Kim
    Paehler, Axel
    Best, Stuart
    Guba, Wolfgang
    Alanine, Thomas
    Halai, Reena
    Charge, Lorna
    Garside, Samantha
    Thom, Stephen
    Incerti-Pradillos, Celia
    Mcpherson, Christopher
    Carrillo, Jokin
    St-Gallay, Steve
    Rigo, Pierre
    Schlicht, Sonja
    Hendrick, Alan G.
    Lerner, Christian
    Piali, Luca
    Blaising, Julie
    Mracsko, Eva Z.
    Jaeschke, Georg
    Cooper, Matthew A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 20911 - 20932
  • [27] Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
    Ohba, Yusuke
    Adachi, Kaoru
    Furukawa, Takayuki
    Nishimaru, Tatsuya
    Sakurai, Kentaro
    Masuo, Ritsuki
    Inami, Tasuku
    Orita, Takuya
    Akai, Shota
    Adachi, Tsuyoshi
    Usui, Kenji
    Hamada, Yuji
    Mori, Mutsuki
    Kurimoto, Takafumi
    Wakashima, Takeshi
    Akiyama, Yoshiyuki
    Miyazaki, Susumu
    Noji, Satoru
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1833 - 1838
  • [28] Identification and Characterization of Novel NLRP3 Inflammasome Inhibitors for the Potential Treatment of Retinal Disease
    Rodriguez, Mirna
    Meng, Frank
    Bishop, Michael
    Perlroth, D. Victor
    Liang, Hong
    Jandeleit, Bernd
    Williams, Kim
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer
    Albanese, Valentina
    Missiroli, Sonia
    Perrone, Mariasole
    Fabbri, Martina
    Boncompagni, Caterina
    Pacifico, Salvatore
    De Ventura, Tiziano
    Ciancetta, Antonella
    Dondio, Giulio
    Kricek, Franz
    Pinton, Paolo
    Guerrini, Remo
    Preti, Delia
    Giorgi, Carlotta
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5223 - 5241
  • [30] NLRP3 Inflammasome: a Novel Insight into Heart Failure
    Wang, Yunjiao
    Li, Yanyang
    Zhang, Wanqin
    Yuan, Zhuo
    Lv, Shichao
    Zhang, Junping
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2023, 16 (01) : 166 - 176